Educational guide
AHK-Cu: Dosage, Benefits, FDA Status & Clinics (2026)
What Is AHK-Cu? AHK-Cu is a copper-binding tripeptide — specifically L-alanyl-L-histidyl-L-lysine complexed with a Cu²⁺ ion — that's attracted attention in skin biology and hair research for its ability to activate fibroblasts and influence how the body builds
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
What Is AHK-Cu?
AHK-Cu is a copper-binding tripeptide — specifically L-alanyl-L-histidyl-L-lysine complexed with a Cu²⁺ ion — that's attracted attention in skin biology and hair research for its ability to activate fibroblasts and influence how the body builds and remodels connective tissue. It's a close structural cousin to GHK-Cu, the better-studied copper peptide, but with alanine substituted for glycine at the first position. That single amino acid swap changes its behavior enough to make it worth studying on its own terms.
The research is still early. Everything published so far comes from cell culture and tissue studies — no human clinical trials have been completed, and the compound carries no FDA approval for any medical use. What the preclinical data does show is genuinely interesting: AHK-Cu appears to push fibroblasts toward repair and regeneration rather than scarring, and it shows early promise for hair follicle stimulation in ex vivo human tissue models.[1]
If you're looking at AHK-Cu, you're probably either a researcher, a formulator working on topical cosmeceuticals, or someone who's already familiar with copper peptides and wants to understand how this one compares. This page covers what the science actually shows — and where the gaps are.
AHK-Cu is a synthetic tripeptide copper complex studied for collagen synthesis, extracellular matrix remodeling, and hair follicle stimulation — not an FDA-approved drug.